FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis

Share this content:
FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis
FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis
Food and Drug Administration today announced that it granted the first-ever waiver, under certain laboratory regulations, for a rapid screening test for syphilis, which will allow the Syphilis Health Check test to be used in a greater variety of health care settings. The waiver also allows untrained health care workers to perform the tests on patients.
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »